We did not observe any significant differences in concentrations of circulating cytokines in carriers of the risk variant (Figure 5B), although the inclusion of the PNPLA3 allele status as a second parameter, in addition to a cytokine, slightly improved HCC prediction models (Figure 5C). The gene discussed is PNPLA3; the disease is hepatocellular carcinoma.